Healthcare industry data research solutions by iDataResearch.com today
Excellent healthcare data research experts with iDataResearch.com: iData Research was founded on a simple principle: providing accessible market research solutions to empower strategic decisions. Today, a number of clients rely on iData for their medical device, dental, and pharmaceutical industry reports to better prepare for the future fluctuations within their markets. We partner with some of the world’s most well-known medical device companies such as Johnson and Johnson, Medtronic, Stryker, 3M, Olympus, Zimmer Biomet, Dentsply Sirona, and Arthrex to help their communities of sales, marketing, and product managers get the benefits and competitive edge they need to remain on top. Read more details on iData.
For every market study, iData’s analyst team study global procedural volumes, product and brand unit sales variations and pricing strategies. We also conduct extensive primary interviews with industry experts to identify key market trends and create accurate market forecasts. Interviews with government regulators, company executives, marketing and product managers shape the scope of research, support data projections, and give insights into the growth trajectory of the healthcare industry. We assemble detailed information with industry expert opinions when preparing every healthcare marketing report.
Whether you are looking for an overall appreciation of certain global markets; or a deep understanding of a specific industry in a particular geography and year; or even identifying the number of surgeries/procedures performed in a country, we can provide you with the necessary information presented in various formats. MedPro reports cover the volume of procedures for all major segments mentioned in the full related Medsuite. All procedures are derived from a number of sources including CPT, ICD and DRG codes as appropriate. The procedure volumes also include a 10-year span of forecast similar to other data types.
MedSKU uses a sample of 1700+ reporting hospitals and ambulatory surgery centers (ASCs) to gather purchase order data and sales information. After combining this with rigorous primary research, ongoing for over a decade, MedSKU is able to deliver a cross-verified and highly accurate depiction of the market, unlike any other. This is used to identify growth opportunities and guide strategic market positioning. Clients have reported tangible increase in market share through optimum price labelling and implementing the best practices of their competitors, using MedSKU.
iData Online : An integrated online solution to provide access to reports and custom solutions on platforms such as personal computers, tablets, and cell phones. You can access thousands of market segments, charts, and excel tables online. Search within a document or across the entire catalogue. Whether at work, home, conference, or traveling, you can rely on iData Online to be your constant intelligent companion. These dashboards are custom built for every client and integrated with their existing platforms as required. Products that are integrated with such dashboards are MedSKU, Procedure Tracker, and Surveys. The main aim of such deliverables is to make the process of studying such large datasets easier and the emerging trends and potential conclusions, more seamless.
Procedure Tracker gives you data and analytics in medical procedures. This volume-tracking tool measures surgical and diagnostic procedures in Hospitals, Ambulatory Surgery Centers (ASCs), Office-based Labs (OBLs) and Private Clinics, by payers and physicians. Well-over 70,000 ICD, CPT and DRG codes and over 100 Million procedures are screened, analyzed, parsed and categorized on a case-by-case basis to preserve data integrity. The true picture of the market landscape is built and made accessible through customized dashboards for easy interaction. Market research surveys can reveal truths about the competitive landscape that might not have been obvious. For instance, they can demonstrate that a target market strategy should be revisited because too much money is being spent to pursue an unprofitable market segment.
